WHO SHOULD RECEIVE LEUKODEPLETED BLOOD COMPONENTS

被引:2
作者
ANDERSON, KC
机构
[1] Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA 02115
来源
TRANSFUSION SCIENCE | 1992年 / 13卷 / 01期
关键词
D O I
10.1016/0955-3886(92)90132-Z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:107 / 109
页数:3
相关论文
共 26 条
[1]  
Wenz, Leukocyte-free red cells: the evolution of a safer blood product, Controversies of Leukocyte-Poor Blood and Components, pp. 27-48, (1989)
[2]  
Anderson, Gorgone, Wahlers, Cook, Barrett, Andersen, Preparation and utilization of leukocyte poor apheresis platelets, Transfus Sci, 12, pp. 163-170, (1991)
[3]  
Bodensteiner, A flow cytometric technique to accurately measure post-filtration white blood cell counts, Transfusion, 29, pp. 651-653, (1989)
[4]  
Dzik, Ragosta, Cusack, Flow-cytometric method for counting very low numbers of leukocytes in platelet products, Vox Sang, 59, pp. 153-159, (1990)
[5]  
Fisher, Chapman, Tung, Morris, Alloimmunization to HLA antigens following transfusion with leukocyte-poor and purified platelet suspensions, Vox Sang, 49, pp. 331-335, (1985)
[6]  
Murphy, Metcalf, Thomas, Eve, Ord, Lister, Waters, Use of leukocyte-poor blood components and HLA-matched platelet donors to prevent HLA alloimmunization, Br J Haematol, 62, pp. 529-534, (1986)
[7]  
Brand, Claas, Voogt, Wasser, Eernisse, Alloimmunization after leukocyte depleted multiple random donor platelet transfusions, Vox Sang, 54, pp. 160-166, (1988)
[8]  
Andreu, Dewailly, Leberre, Quarre, Bidet, Tardivel, Devers, Lam, Soreau, Boccaccio, Piard, Bidet, Genetet, Fauchet, Prevention of HLA immunizations with leukocyte-poor packed red cells and platelet concentrates obtained by filtration, Blood, 72, pp. 964-969, (1988)
[9]  
Sniecinski, O'Donnell, Nowicki, Hill, Prevention of refractoriness and HLA alloimmunization using filtered blood products, Blood, 71, pp. 1402-1407, (1988)
[10]  
Saarinen, Kekomaki, Siimes, Myllyla, Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components, Blood, 75, pp. 512-517, (1990)